Following the COVID-19 led slump in March 2020, the S&P/TSX Composite Index bounced back by 56 per cent in the last three quarters of the year. The index gained 2.2 per cent last year, led by surge rallies in technology, biotechnology, and gold stocks.
In this article, we explore the top stocks on the Toronto Stock Exchange that saw massive growth on the TSX, scripting new heights despite the pandemic-led market meltdown.
Here are the three stocks from the TSX’s investor insights report, that catapulted to new heights and continue on their growth path in 2021:
Trillium Therapeutics Inc. (TSX: TRIL)
Current TRIL Stock Price: C$ 16.43
The therapeutics stock grew by an eye-popping 1308 per cent in 2020. The immuno-oncology company researches and develops therapies for cancer treatment. It received C$ 150 million from Pfizer Inc. last year for the development of its two clinical cancer therapies, TTI-622 and TTI-621.
Trillium held C$ 300 million working capital for its research and development, as reported on November 30, 2020. It generated revenue of C$ 115 million in the third quarter of 2020, ended September 30, down from C$ 124 million in Q3 2019.
However, the stock is down over 12 per cent month-to-date (January).
Docebo Inc. (TSX: DCBO)
Current DCBO Stock Price: C$ 67.77
The midcap software company provides cloud-based learning solutions. The stock did well in 2020, with an 82.75 per cent yearly growth. The surge was amplified by the work from home model during lockdowns.
It had 32.6 million listed shares outstanding (as of January 22, 2020) and a current price-to-book ratio of nearly 48.95.
In its preliminary fourth quarter 2020 earnings (ended December 31, 2020), Docebo said its revenue is projected to be in the range of $18.25 million to $18.75 million, a rise of 48 per cent to 52 per cent from Q4 2019.
Image Source: Kalkine Group @2020
Aura Minerals Inc. (TSX: ORA)
Current ORA Stock Price: C$ 14
The US-based mining firm explores and produces gold. Its shares soared 764 per cent last year, driven by high gold prices.
The precious metal shares have an 18.58 per cent return on equity, with earnings per share of C$ 0.80.
In its estimated Q4 2020 report, Aura anticipated a record production of 68,964 gold equivalent ounces (GEO*) against 53,386 GEO in Q4 of 2019. In its guidance report for 2021, the company expects production growth in a range of 22 per cent to 42 per cent.
The GOE has been assessed by switching the production of copper and silver into gold applying a ratio of the prices of the base metals to that of gold.